PubRank

Kojiro Taura

Author PubWeight™ 48.66‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 CCR2 promotes hepatic fibrosis in mice. Hepatology 2009 2.35
2 Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma. J Gastroenterol 2009 2.23
3 Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice. Hepatology 2009 1.83
4 Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity. Hepatology 2008 1.81
5 c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice. Gastroenterology 2009 1.59
6 CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury. Am J Physiol Gastrointest Liver Physiol 2008 1.52
7 Antiapoptotic effect of c-Jun N-terminal Kinase-1 through Mcl-1 stabilization in TNF-induced hepatocyte apoptosis. Gastroenterology 2009 1.45
8 A phosphodiesterase III inhibitor protects rat liver from sinusoidal obstruction syndrome through heme oxygenase-1 induction. Ann Surg 2009 1.44
9 Proliferative activity in hepatocellular carcinoma is closely correlated with glucose metabolism but not angiogenesis. J Hepatol 2011 1.19
10 Sorafenib attenuates monocrotaline-induced sinusoidal obstruction syndrome in rats through suppression of JNK and MMP-9. J Hepatol 2012 1.17
11 Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist. Proc Natl Acad Sci U S A 2012 1.16
12 Prognostic index for patients with hepatocellular carcinoma combined with tumor thrombosis in the major portal vein. J Am Coll Surg 2006 1.12
13 A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer. Cancer Chemother Pharmacol 2010 1.08
14 An eClinical trial system for cancer that integrates with clinical pathways and electronic medical records. Clin Trials 2012 1.01
15 A TLR4/MD2 fusion protein inhibits LPS-induced pro-inflammatory signaling in hepatic stellate cells. Biochem Biophys Res Commun 2008 0.94
16 Effect of heat shock preconditioning on NF-kappaB/I-kappaB pathway during I/R injury of the rat liver. Am J Physiol Gastrointest Liver Physiol 2002 0.91
17 Systemic mediators induce fibrogenic effects in normal liver after partial bile duct ligation. Liver Int 2006 0.90
18 Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with extrahepatic bile duct cancer. J Hepatobiliary Pancreat Sci 2010 0.90
19 High risk of lung metastasis after resection of hepatocellular carcinoma more than 7 cm in diameter. Surg Today 2013 0.89
20 Validation of the Conventional Resection Criteria in Patients with Hepatocellular Carcinoma in Terms of the Incidence of Posthepatectomy Liver Failure and Long-Term Prognosis. Dig Surg 2015 0.88
21 High volume hydrodynamic injection of plasmid DNA via the hepatic artery results in a high level of gene expression in rat hepatocellular carcinoma induced by diethylnitrosamine. J Gene Med 2006 0.88
22 Hepatocellular carcinoma with bile duct tumor thrombus: surgical outcomes and the prognostic impact of concomitant major vascular invasion. World J Surg 2015 0.88
23 A single-center analysis of the survival benefits of adjuvant gemcitabine chemotherapy for biliary tract cancer. Int J Clin Oncol 2013 0.88
24 Downregulation of the Wnt antagonist Dkk2 links the loss of Sept4 and myofibroblastic transformation of hepatic stellate cells. Biochim Biophys Acta 2011 0.87
25 Laparoscopic liver resection in obese patients. World J Surg 2015 0.87
26 Non-alcoholic steatohepatitis-induced fibrosis: Toll-like receptors, reactive oxygen species and Jun N-terminal kinase. Hepatol Res 2011 0.87
27 Loss of Sept4 exacerbates liver fibrosis through the dysregulation of hepatic stellate cells. J Hepatol 2008 0.86
28 Pancreatic arteriovenous malformation with portal hypertension. J Hepatobiliary Pancreat Surg 2006 0.85
29 Olprinone attenuates excessive shear stress through up-regulation of endothelial nitric oxide synthase in a rat excessive hepatectomy model. Liver Transpl 2011 0.85
30 Preoperative FDG-PET predicts recurrence patterns in hepatocellular carcinoma. Ann Surg Oncol 2011 0.83
31 Effects of oral intake of hydrogen water on liver fibrogenesis in mice. Hepatol Res 2013 0.83
32 Septic complication after balloon-occluded retrograde transvenous obliteration of duodenal variceal bleeding. Cardiovasc Intervent Radiol 2009 0.83
33 Effect of olprinone on liver microstructure in rat partial liver transplantation. J Surg Res 2012 0.82
34 Early evaluation of transcatheter arterial chemoembolization-refractory hepatocellular carcinoma. J Gastroenterol 2011 0.81
35 Beneficial effect of cepharanthine on overcoming drug-resistance of hepatocellular carcinoma. Int J Oncol 2004 0.81
36 The impact of posthepatectomy liver failure on the recurrence of hepatocellular carcinoma. World J Surg 2014 0.80
37 Impact of Hepatic Steatosis on Disease-Free Survival in Patients with Non-B Non-C Hepatocellular Carcinoma Undergoing Hepatic Resection. Ann Surg Oncol 2014 0.80
38 Induction of heme oxygenase-1 and dilatation of hepatic sinusoids by an administration of pyrrolidine dithiocarbamate in rat livers. J Surg Res 2003 0.80
39 [Efficacy and toxicity of transcatheter arterial chemoembolization with Cisplatin suspended in lipiodol for unresectable hepatocellular carcinoma]. Gan To Kagaku Ryoho 2008 0.80
40 Complete response by a combination of 5-fluorouracil and interferon-alpha chemotherapy for lung metastasis of hepatocellular carcinoma after hepatic resection with portal and hepatic vein tumor thrombectomy. Hepatol Res 2005 0.80
41 Soluble thrombomodulin attenuates sinusoidal obstruction syndrome in rat through suppression of high mobility group box 1. Liver Int 2014 0.80
42 Hepatoprotective effect by pretreatment with olprinone in a swine partial hepatectomy model. Liver Transpl 2014 0.80
43 Comparative study of cisplatin and epirubicin in transcatheter arterial chemoembolization for hepatocellular carcinoma. Hepatol Res 2011 0.79
44 Attenuation of steatohepatitis, fibrosis, and carcinogenesis in mice fed a methionine-choline deficient diet by CCAAT/enhancer-binding protein homologous protein deficiency. J Gastroenterol Hepatol 2014 0.79
45 Hepatic Resection for Hepatocellular Carcinoma with Tumor Thrombus in the Major Portal Vein. Dig Surg 2015 0.78
46 Role of preferential cyclooxygenase-2 inhibition by meloxicam in ischemia/reperfusion injury of the rat liver. Eur Surg Res 2014 0.78
47 [Complete remission of hepatocellular carcinoma with multiple lung metastases by oral administration of tegafur/uracil]. Gan To Kagaku Ryoho 2013 0.78
48 Phase I study of adjuvant gemcitabine or S-1 in patients with biliary tract cancers undergoing major hepatectomy: KHBO1003 study. Cancer Chemother Pharmacol 2014 0.78
49 Indication for neoadjuvant chemotherapy in patients with colorectal liver metastases based on a nomogram that predicts disease-free survival. J Hepatobiliary Pancreat Sci 2014 0.77
50 Blocking of PI3K/Akt pathway enhances apoptosis induced by SN-38, an active form of CPT-11, in human hepatoma cells. Int J Oncol 2005 0.76
51 Mesothelin/mucin 16 signaling in activated portal fibroblasts regulates cholestatic liver fibrosis. J Clin Invest 2017 0.75
52 Assessment of [(18)F]-fluoroacetate PET/CT as a tumor-imaging modality: preclinical study in healthy volunteers and clinical evaluation in patients with liver tumor. Ann Nucl Med 2014 0.75
53 Deformable resection process map for intraoperative cutting guides. Conf Proc IEEE Eng Med Biol Soc 2016 0.75
54 Real-time Navigation for Liver Surgery Using Projection Mapping With Indocyanine Green Fluorescence: Development of the Novel Medical Imaging Projection System. Ann Surg 2017 0.75
55 Intraoperative fluorescent cholangiography using indocyanine green for laparoscopic fenestration of nonparasitic huge liver cysts. Asian J Endosc Surg 2015 0.75
56 Pancreatic Stellate Cells Have Distinct Characteristics From Hepatic Stellate Cells and Are Not the Unique Origin of Collagen-Producing Cells in the Pancreas. Pancreas 2017 0.75
57 Sorafenib in a hepatocellular carcinoma patient with end-stage renal failure: A pharmacokinetic study. Hepatol Res 2013 0.75
58 [Clinical impact of PET/CT on the management of patients with intrahepatic cholangiocarcinoma]. Nihon Shokakibyo Gakkai Zasshi 2012 0.75
59 Usefulness of Mac-2 Binding Protein Glycosylation Isomer for Prediction of Posthepatectomy Liver Failure in Patients With Hepatocellular Carcinoma. Ann Surg 2017 0.75
60 Impact of Sarcopenic Obesity on Outcomes in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma. Ann Surg 2017 0.75